Fig. 5From: Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimusa OXPHOS metabolism associated with metformin treatment. b glycolysis after metformin treatment and c metabolic phenotype. All analysis were performed after 18 h treatment with 5 mM of metformin. Red line is metformin and blue line media controlBack to article page